A Novel Cell Transplantation Platform

Quick Links

Disclose Your Invention
MTA/CDA Assistance
Technologies for Licensing
Industry Collaboration Opportunities
Research and Clinical Trials
Education Links
Office of Sponsored Research

Categories:  “Other Disorders”  “Medical & Research Devices

Reference #: 2018-002

OTC Contact: Ruchika Nijhara, Ph.D., MBA, CLP (Directory Information | Send a Message)


A cell transplantation method that utilizes a sealed transplantation space – wherein decellularized human amniotic membranes provides human islet grafts with a extracellular metrics-like support, and human amniotic epithelial cells (HAECs) improve new blood vessel formation due to their stem cell-like features- are attached to the surface of a visceral organ in order to restore or increase normal function.



Stage of Development

Animal studies and preliminary in vitro testing.


Wanxing Cui

Patent Status

IP protected